{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:33:13Z","timestamp":1748320393191},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00432-022-04419-x","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T16:03:03Z","timestamp":1668355383000},"page":"5193-5204","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients"],"prefix":"10.1007","volume":"149","author":[{"given":"Mary K.","family":"Munsell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temidayo","family":"Fadelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherri O.","family":"Stuver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine P.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Glotzbecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin L.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry L.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,13]]},"reference":[{"issue":"9","key":"4419_CR1","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1210\/jc.2010-0305","volume":"95","author":"A Abbasi","year":"2010","unstructured":"Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, De Jong PE, Gans ROB, Struck J et al (2010) Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. J Clin Endocr Metab 95(9):E26-31. https:\/\/doi.org\/10.1210\/jc.2010-0305","journal-title":"J Clin Endocr Metab"},{"issue":"1","key":"4419_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1871526515666150320162950","volume":"15","author":"V Avrillon","year":"2015","unstructured":"Avrillon V, Locatelli-Sanchez M, Folliet L, Carbonnaux M, Perino E, Fossard G, Desseigne M et al (2015) Lung cancer may increase serum procalcitonin level. Infect Disord Drug Targets 15(1):57\u201363. https:\/\/doi.org\/10.2174\/1871526515666150320162950","journal-title":"Infect Disord Drug Targets"},{"key":"4419_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13104-018-3204-1","volume":"11","author":"SA Aziz","year":"2018","unstructured":"Aziz SA, Nelwan EJ, Sukrisman L, Suhendro S (2018) Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients. BMC Res Notes 11:84. https:\/\/doi.org\/10.1186\/s13104-018-3204-1","journal-title":"BMC Res Notes"},{"issue":"6","key":"4419_CR4","first-page":"339","volume":"10","author":"A Bansal","year":"2020","unstructured":"Bansal A, Jeyaraman P, Gupta SK, Dayal N, Naithani R (2020) Clinical utility of procalcitonin in bacterial infections in patients undergoing hematopoietic stem cell transplantation. Am J Blood Res 10(6):339\u2013344","journal-title":"Am J Blood Res"},{"key":"4419_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG et al (2015) STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. Brit Med J 351:h5527","journal-title":"Brit Med J"},{"key":"4419_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00432-009-0699-9","volume":"136","author":"L Carnino","year":"2010","unstructured":"Carnino L, Betteto S, Loiacono M et al (2010) Procalcitonin as a predictive marker of infections in chemoinduced neutropenia. J Cancer Res Clin Oncol 136:611\u2013615. https:\/\/doi.org\/10.1007\/s00432-009-0699-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"4419_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/ard.62.4.337","volume":"62","author":"I Del\u00e9vaux","year":"2003","unstructured":"Del\u00e9vaux I, Andr\u00e9 M, Colombier M, Albuisson E, Meylheuc F, B\u00e9gue RJ, Piette JC, Auma\u00eetre O (2003) Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 62(4):337\u2013340. https:\/\/doi.org\/10.1136\/ard.62.4.337","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4419_CR41","first-page":"A4984","volume":"61","author":"LV Diness","year":"2014","unstructured":"Diness LV, Maraldo MV, Mortensen CE, Mellemgaard A, Larsen FO (2014) Procalcitonin and C-reactive protein as markers of bacterial infection in patients with solid tumours. Dan Med J 61(12):A4984","journal-title":"Dan Med J"},{"key":"4419_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/OTT.S95600","volume":"9","author":"B Durnas","year":"2016","unstructured":"Durnas B, Watek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, Gozdz S (2016) Utility of blood procalcitonin concentration in the management of cancer patients with infections. Onco Targets Ther 9:469\u2013475. https:\/\/doi.org\/10.2147\/OTT.S95600","journal-title":"Onco Targets Ther"},{"key":"4419_CR10","unstructured":"Elecsys BRAHMS PCT [package insert] (2020) Indianapolis, IN: Roche Diagnostics"},{"issue":"8","key":"4419_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1515\/CCLM.2010.214","volume":"48","author":"L Giovanella","year":"2010","unstructured":"Giovanella L, Suriano S, Ricci R, Ravani P, Ceriani L (2010) Circulating procalcitonin in aseptic carcinoma patients: A specificity study with (18)F-fluorodeoxyglucose positron-emission tomography\/computed tomography as benchmark. Clin Chem Lab Med 48(8):1163\u20131165. https:\/\/doi.org\/10.1515\/CCLM.2010.214","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"4419_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pop.2018.04.001","volume":"45","author":"SN Grief","year":"2018","unstructured":"Grief SN, Loza JK (2018) Guidelines for the evaluation and treatment of pneumonia. Prim Care 45(3):485\u2013503. https:\/\/doi.org\/10.1016\/j.pop.2018.04.001","journal-title":"Prim Care"},{"key":"4419_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.636547","volume":"8","author":"C Gudiol","year":"2021","unstructured":"Gudiol C, Albasanz-Puig A, Cuervo G, Carratal\u00e0 J (2021) Understanding and managing sepsis in patients with cancer in the era of antimicrobial resistance. Front Med 8:636547. https:\/\/doi.org\/10.3389\/fmed.2021.636547","journal-title":"Front Med"},{"key":"4419_CR14","doi-asserted-by":"publisher","unstructured":"Habibzadeh F, Habibzadeh P, Yadollahie M (2016) On determining the most appropriate test cut-off value: The case of tests with continuous results. Biochem Med 26(3):297\u2013307. https:\/\/doi.org\/10.11613\/BM.2016.034","DOI":"10.11613\/BM.2016.034"},{"issue":"6","key":"4419_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"Kamir J. Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH (2021) Systemic immunity in cancer. Nat Rev Cancer 21(6):345\u2013359. https:\/\/doi.org\/10.1038\/s41568-021-00347-z","journal-title":"Nature Reviews Cancer"},{"issue":"5","key":"4419_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","volume":"21","author":"SH Hoeboer","year":"2015","unstructured":"Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld ABJ (2015) The diagnostic accuracy of procalcitonin for bacteraemia: A systematic review and meta-analysis. Clin Microbiol Infect 21(5):474\u2013481. https:\/\/doi.org\/10.1016\/j.cmi.2014.12.026","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"4419_CR16","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/cncr.20275","volume":"100","author":"A Jimeno","year":"2004","unstructured":"Jimeno A, Garcia-Velasco A, Del Val O, Gonzalez-Billalabeitia E, Hernando S, Hernandez R, Sanchez-Munoz A, Lopez-Martin A, Duran I, Robles L, Cortes-Funes H, Paz-Ares L (2004) Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 100(11):2462\u20132469. https:\/\/doi.org\/10.1002\/cncr.20275","journal-title":"Cancer"},{"issue":"1","key":"4419_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.annemergmed.2006.10.020","volume":"50","author":"AE Jones","year":"2007","unstructured":"Jones AE, Fiechti JF, Brown MD, Ballew JJ, Kline JA (2007) Procalcitonin test in the diagnosis of bacteremia: A meta-analysis. Ann Emerg Med 50(1):34\u201341. https:\/\/doi.org\/10.1016\/j.annemergmed.2006.10.020","journal-title":"Ann Emerg Med"},{"issue":"3","key":"4419_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/cid\/ciz545","volume":"70","author":"IS Kamat","year":"2020","unstructured":"Kamat IS, Ramachandran V, Eswaran H, Guffey D, Musher DM (2020) Procalcitonin to distinguish viral from bacterial pneumonia: A systematic review and meta-analysis. Clin Infect Dis 70(3):538\u2013542. https:\/\/doi.org\/10.1093\/cid\/ciz545","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4419_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4143\/crt.2011.43.3.176","volume":"43","author":"DY Kim","year":"2011","unstructured":"Kim DY, Lee YS, Ahn S, Chun YH, Lim KS (2011) The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat 43(3):176\u2013180. https:\/\/doi.org\/10.4143\/crt.2011.43.3.176","journal-title":"Cancer Res Treat"},{"issue":"2","key":"4419_CR43","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1016\/j.bbmt.2010.12.381","volume":"17","author":"S. Kohashi","year":"2011","unstructured":"Kohashi S, Nawa Y, Matsubara E, Nakase K, Hara M (2011) Use of procalcitonin measurements to diagnose infection in allogeneic hematopoietic stem cell transplantation patients with fever. Biol Blood Marrow Transplant 17(2):S279\u2013S280. https:\/\/doi.org\/10.1016\/j.bbmt.2010.12.381","journal-title":"Biol Blood Marrow Transplant"},{"key":"4419_CR20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/bmt.2012.18","volume":"47","author":"J Koya","year":"2012","unstructured":"Koya J, Nannya Y, Ichikawa M, Kurokawa M (2012) The clinical role of procalcitonin in hematopoietic SCT. Bone Marrow Transplant 47:1326\u20131331. https:\/\/doi.org\/10.1038\/bmt.2012.18","journal-title":"Bone Marrow Transplant"},{"key":"4419_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/701480","volume":"2015","author":"C Leli","year":"2015","unstructured":"Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A (2015) Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers 2015:701480. https:\/\/doi.org\/10.1155\/2015\/701480","journal-title":"Dis Markers"},{"issue":"1","key":"4419_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/annonc\/mdu192","volume":"26","author":"G Maschmeyer","year":"2015","unstructured":"Maschmeyer G, Carratal\u00e0 J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J et al (2015) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): Updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26(1):21\u201333. https:\/\/doi.org\/10.1093\/annonc\/mdu192","journal-title":"Ann Oncol"},{"issue":"5\u20136","key":"4419_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.clinbiochem.2006.10.027","volume":"40","author":"V Matzaraki","year":"2007","unstructured":"Matzaraki V, Alexandraki KI, Venetsanou K et al (2007) Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem 40(5\u20136):336\u2013342. https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.10.027","journal-title":"Clin Biochem"},{"issue":"S2","key":"4419_CR25","doi-asserted-by":"publisher","first-page":"S212","DOI":"10.1007\/BF02900740","volume":"26","author":"M Meisner","year":"2000","unstructured":"Meisner M, Schmidt J, Huttner H, Tschaikowsky K (2000) The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 26(S2):S212\u2013S216. https:\/\/doi.org\/10.1007\/BF02900740","journal-title":"Intensive Care Med"},{"key":"4419_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684110","volume":"11","author":"V Nardone","year":"2021","unstructured":"Nardone V, Giannicola R, Bianco G, Giannarelli D, Tini P, Pastina P, Falzea AC et al (2021) Inflammatory markers and procalcitonin predict the outcome of metastatic non-small-cell-lung-cancer patients receiving PD-1\/PD-L1 immune-checkpoint blockade. Front Oncol 11:684110. https:\/\/doi.org\/10.3389\/fonc.2021.684110","journal-title":"Front Oncol"},{"issue":"18","key":"4419_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clinbiochem.2014.09.002","volume":"47","author":"M Patout","year":"2014","unstructured":"Patout M, Salaun M, Brunel V, Bota S, Cauliez B, Thiberville L (2014) Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers. Clin Biochem 47(18):263\u2013267. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.09.002","journal-title":"Clin Biochem"},{"issue":"3","key":"4419_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MCP.0b013e328351f953","volume":"18","author":"JH Reynolds","year":"2012","unstructured":"Reynolds JH, Banerjee AK (2012) Imaging pneumonia in immunocompetent and immunocompromised individuals. Curr Opin Pulm Med 18(3):194\u2013201. https:\/\/doi.org\/10.1097\/MCP.0b013e328351f953","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"4419_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","volume":"6","author":"KVI Rolston","year":"2017","unstructured":"Rolston KVI (2017) Infections in cancer patients with solid tumors: A review. Infect Dis Ther 6(1):69\u201383. https:\/\/doi.org\/10.1007\/s40121-017-0146-1","journal-title":"Infect Dis Ther"},{"issue":"2","key":"4419_CR30","first-page":"59","volume":"38","author":"I Samsudin","year":"2017","unstructured":"Samsudin I, Vasikaran SD (2017) Clinical utility and measurement of procalcitonin. Clin Biochem Rev 38(2):59\u201368","journal-title":"Clin Biochem Rev"},{"key":"4419_CR42","doi-asserted-by":"crossref","unstructured":"Sandri MT, Passerini R, Leon ME, Peccatori FA, Zorzino L, Salvatici M, Riggio D et al (2008) Procalcitonin as a useful marker of infection in hemato-oncological patients with fever. Anticancer Res 28(5B):3061\u20133065","DOI":"10.1007\/s10096-008-0594-3"},{"issue":"1","key":"4419_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L et al (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: A patient-level meta-analysis. Lancet Infect Dis 18(1):95\u2013107. https:\/\/doi.org\/10.1016\/S1473-3099(17)30592-3","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"4419_CR32","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1002\/cncr.27602","volume":"118","author":"W Shomali","year":"2012","unstructured":"Shomali W, Hachem R, Chaftari AM, Jiang Y, Bahu R, Jabbour J, Raad S et al (2012) Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer 118(23):5823\u20135829. https:\/\/doi.org\/10.1002\/cncr.27602","journal-title":"Cancer"},{"issue":"4","key":"4419_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/jccm-2015-0022","volume":"1","author":"J Szederjesi","year":"2015","unstructured":"Szederjesi J, Almasy E, Lazar A, Hutanu A, Badea I, Georgescu A (2015) An evaluation of serum procalcitonin and C-reactive protein levels as diagnostic and prognostic biomarkers of severe sepsis. J Crit Care Med 1(4):147\u2013153. https:\/\/doi.org\/10.1515\/jccm-2015-0022","journal-title":"J Crit Care Med"},{"issue":"1","key":"4419_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5114\/wo.2013.33777","volume":"17","author":"B Tulek","year":"2013","unstructured":"Tulek B, Koylu H, Kanat F, Arslan U, Ozer F (2013) Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients. Contemp Oncol 17(1):68\u201372. https:\/\/doi.org\/10.5114\/wo.2013.33777","journal-title":"Contemp Oncol"},{"key":"4419_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-018-2125-7","volume":"22","author":"Y Wirz","year":"2018","unstructured":"Wirz Y, Meier MA, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F et al (2018) Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: A patient-level meta-analysis of randomized trials. Crit Care 22:191\u2013202. https:\/\/doi.org\/10.1186\/s13054-018-2125-7","journal-title":"Crit Care"},{"issue":"1","key":"4419_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/iju.12178","volume":"21","author":"H Yaegashi","year":"2014","unstructured":"Yaegashi H, Izumi K, Kitagawa Y, Kadono Y, Konaka H, Mizokami A, Namiki M (2014) Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: The role of procalcitonin. Int J Urol 21(1):104\u2013106. https:\/\/doi.org\/10.1111\/iju.12178","journal-title":"Int J Urol"},{"issue":"12","key":"4419_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225765","volume":"14","author":"M Yang","year":"2019","unstructured":"Yang M, Choi SJ, Lee J, Lee DG, Kim YJ, Park YJ, Oh EJ (2019) Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies. PLoS ONE 14(12):e0225765. https:\/\/doi.org\/10.1371\/journal.pone.0225765","journal-title":"PLoS ONE"},{"key":"4419_CR39","doi-asserted-by":"publisher","unstructured":"Zhou H, Guo S, Lan T, Ma S, Zhang F, Zhao Z. (2018) Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED. Am J Emerg Med 36(12):2155\u20132160. https:\/\/doi.org\/10.1016\/j.ajem.2018.03.050","DOI":"10.1016\/j.ajem.2018.03.050"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04419-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T14:18:18Z","timestamp":1689430698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04419-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,13]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4419"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04419-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,13]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant financial or non-financial interests to disclose. The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}